Onesource Specialty Pharma Ltd. (ONESOURCE) - Stock Overview & Analysis

Search your stocks

Profile

ONESOURCEOnesource Specialty Pharma Ltd.

₹1840.5-1.04%

Market Cap

₹21,550.52 Cr

Stock P/E

1077.55

ROCE

2.61%

ROE

-0.55%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Institution

Public

Others

Financials

YoY Net Sales

EPS Growth

Operating Margin

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Onesource Specialty Pharma Ltd. is significantly underperforming across all key financial metrics compared to its peers in the Pharmaceuticals & Drugs sector. Companies like Cipla Ltd. and Sun Pharmaceutical Industries Ltd. show strong profitability and growth, making them sector leaders, while Onesource is financially weak with negative margins and high debt levels.

Key Points

• Onesource has the lowest revenue growth, EPS, ROE, ROA, and profitability metrics.
• Cipla and Sun Pharmaceutical stand out as top performers in profitability and valuation metrics.
• Onesource’s extremely high P/E ratio indicates it is overvalued compared to peers.

Top Performers

Cipla Ltd.

Highest ROE and EBITDA margin, strong growth in revenue and EPS.

Sun Pharmaceutical Industries Ltd.

Strong revenue growth and profitability metrics, low debt levels.

Dr. Reddy's Laboratories Ltd.

Consistent growth in revenue, EPS, and strong profitability metrics.